TD Ameritrade Investment Management’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-30	Closed	-$7K	–	632
2021 Q3	$7K	Buy	30 +7	+30%	+$2.91K	﹤0.01%	481
2021 Q2	$9K	Sell	23 -7	-23%	-$2.34K	﹤0.01%	472
2021 Q1	$7K	Hold	30	–	–	﹤0.01%	503
2020 Q4	$7K	Hold	30	–	–	﹤0.01%	503
2020 Q3	$7K	Sell	30 -10	-25%	-$2.08K	﹤0.01%	481
2020 Q2	$7K	Sell	40 -41	-51%	-$6.54K	﹤0.01%	466
2020 Q1	$10K	Buy	81 +11	+16%	+$1.65K	﹤0.01%	411
2019 Q4	$11K	Sell	70 -2	-3%	-$277	﹤0.01%	441
2019 Q3	$10K	Buy	72 +1	+1%	+$134	﹤0.01%	426
2019 Q2	$10K	Sell	71 -4	-5%	-$543	﹤0.01%	389
2019 Q1	$11K	Sell	75 -77	-51%	-$10.1K	﹤0.01%	333
2018 Q4	$17K	Hold	152	–	–	﹤0.01%	311
2018 Q3	$20K	Buy	+152	New	+$18.8K	﹤0.01%	281